These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1377462)

  • 21. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
    Kim A; Ji L; Balmaceda C; Diez B; Kellie SJ; Dunkel IJ; Gardner SL; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2008 Dec; 51(6):768-73. PubMed ID: 18802946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
    Ondrus D; Ondrusova M; Hornak M; Matoska J
    Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum tumour markers in testicular and extragonadal germ cell malignancies.
    Klepp O
    Scand J Clin Lab Invest Suppl; 1991; 206():28-41. PubMed ID: 1947758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of tumor markers in testicular seminomas. Results of a prospective multicenter study.
    Weissbach L; Bussar-Maatz R; Mann K
    Eur Urol; 1997; 32(1):16-22. PubMed ID: 9266226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor.
    Mazumdar M; Bacik J; Tickoo SK; Dobrzynski D; Donadio A; Bajorin D; Motzer R; Reuter V; Bosl GJ
    J Clin Oncol; 2003 Jul; 21(14):2679-88. PubMed ID: 12860944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor markers in testis cancer.
    Klein EA
    Urol Clin North Am; 1993 Feb; 20(1):67-73. PubMed ID: 7679533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The diagnostic and prognostic value of tumor markers in nonseminomatous stage-III to -IV testicular tumors].
    Sakalo VS; Klimenko IA; Iaremko VN; Zaparin VK
    Urol Nefrol (Mosk); 1989; (3):42-6. PubMed ID: 2475955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of plasma tumor markers in germinal tumors of the testis].
    Blacker C; Feinstein MC; Roger M; Zimmer R; Scholler R
    Ann Med Interne (Paris); 1984; 135(5):376-80. PubMed ID: 6207755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in the management of testicular cancer.
    Ellis M; Sikora K
    Drugs Exp Clin Res; 1986; 12(1-3):219-31. PubMed ID: 2426072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sterility and tumors of the testis. Study of late exocrine and endocrine functions in stage I or IIA tumors].
    Bouchot O; Plougastel ML; Karam G; Bochereau G; Auvigne J
    J Urol (Paris); 1989; 95(6):367-71. PubMed ID: 2478640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Morphologic criteria for the evaluation of beta-HCG positive seminoma].
    Scherenberg M; Schubert GE
    Urologe A; 1993 Jan; 32(1):38-42. PubMed ID: 7680507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modified neck dissection for metastatic nonseminomatous testicular carcinoma.
    Weisberger EC; McBride LC
    Laryngoscope; 1999 Aug; 109(8):1241-4. PubMed ID: 10443827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molecular staging of testicular cancer using polymerase chain reaction of the testicular cancer-specific genes].
    Nonomura N; Imazu T; Harada Y; Nozawa M; Ono Y; Fukui T; Nishimura K; Okuyama A
    Hinyokika Kiyo; 1999 Aug; 45(8):593-7. PubMed ID: 10500969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical study of testicular germ cell tumors.
    Tomomasa H; Shimizu H; Sato S; Adachi Y; Ashizawa Y; Kamiyama Y; Okano Y; Sato M; Yoshii T; Iizumi T; Umeda T; Yazaki T
    Hinyokika Kiyo; 2001 Jun; 47(6):389-95. PubMed ID: 11496394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Testicular tumor staging: the ranking of CT and ultrasonic diagnosis].
    Hruby W; Stellamor K; Höltl W; Pont J
    Rontgenblatter; 1984 Apr; 37(4):123-6. PubMed ID: 6729361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evidence of biochemical markers in a complex diagnostico-therapeutic program in germ cell tumors of the testes].
    Abrahámová J; Motlík K; Malbohan I; Wernischová V
    Cas Lek Cesk; 1983 Jul; 122(26):824-9. PubMed ID: 6193884
    [No Abstract]   [Full Text] [Related]  

  • 37. [Differentiated teratoma as late recurrence of metastatic non-seminomatous testicular germ cell tumor. Case report and clinical problems].
    Kuczyk MA; Bokemeyer C; Fichna B; Truss M; Schmoll HJ; Jonas U
    Urologe A; 1995 Nov; 34(6):480-4. PubMed ID: 8848861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic indications for germinal testicular tumors].
    Bourlaud G; Houlgatte A; Merrer J; Pabot du Chatelard P
    Ann Urol (Paris); 1992; 26(2):119-24. PubMed ID: 1616300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tumor markers in testicular cancer].
    Mann K
    Urologe A; 1990 Mar; 29(2):77-86. PubMed ID: 2158684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surveillance after orchidectomy for clinical stage I testicular non-seminoma.
    Peckham MJ
    Prog Clin Biol Res; 1984; 153():155-65. PubMed ID: 6206505
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.